Literature DB >> 17719359

Stress history and breast cancer recurrence.

Oxana Palesh1, Lisa D Butler, Cheryl Koopman, Janine Giese-Davis, Robert Carlson, David Spiegel.   

Abstract

BACKGROUND: There is mixed evidence regarding the possible association between a history of stressful or traumatic life events and more rapid breast cancer progression.
METHOD: Retrospective reports of past experiences of traumatic life events were assessed among 94 women with metastatic or recurrent breast cancer. A traumatic event assessment was conducted using the event-screening question from the posttraumatic stress disorder (PTSD) module of the Structured Clinical Interview for the DSM-IV-TR (SCID; 2002). Each reported event was judged by two independent raters to determine whether it met DSM-IV-TR PTSD A1 criteria for a traumatic event. Those events that did not meet such criteria were designated "stressful events."
RESULTS: Nearly 42% of the women in the sample were judged to have experienced one or more traumatic events; 28.7% reported only stressful events. A Kruskal-Wallis test found significant differences in disease-free interval among the three groups [chi2 (2, N=94)=6.09, P<.05]. Planned comparisons revealed a significantly longer disease-free interval among women who had reported no traumatic or stressful life events (median=62 months) compared to those who had experienced one or more stressful or traumatic life events (combined median=31 months).
CONCLUSIONS: A history of stressful or traumatic life events may reduce host resistance to tumor growth. These findings are consistent with a possible long-lasting effect of previous life stress on stress response systems such as the hypothalamic-pituitary-adrenal (HPA) axis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719359      PMCID: PMC2094358          DOI: 10.1016/j.jpsychores.2007.05.012

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  38 in total

1.  Epigenetic programming of stress responses through variations in maternal care.

Authors:  Eric W Fish; Dara Shahrokh; Rose Bagot; Christian Caldji; Timothy Bredy; Moshe Szyf; Michael J Meaney
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

2.  Life events and breast cancer prognosis.

Authors:  J Barraclough; C Osmond; I Taylor; M Perry; P Collins
Journal:  BMJ       Date:  1993-07-31

3.  The number needed to treat: a clinically useful measure of treatment effect.

Authors:  R J Cook; D L Sackett
Journal:  BMJ       Date:  1995-02-18

4.  Vulnerability to stress-induced tumor growth increases with age in rats: role of glucocorticoids.

Authors:  R M Sapolsky; T M Donnelly
Journal:  Endocrinology       Date:  1985-08       Impact factor: 4.736

5.  Diurnal cortisol rhythm as a predictor of breast cancer survival.

Authors:  S E Sephton; R M Sapolsky; H C Kraemer; D Spiegel
Journal:  J Natl Cancer Inst       Date:  2000-06-21       Impact factor: 13.506

6.  Life events, chronic difficulties and vulnerability factors preceding breast cancer.

Authors:  S Geyer
Journal:  Soc Sci Med       Date:  1993-12       Impact factor: 4.634

Review 7.  Depression and cancer: mechanisms and disease progression.

Authors:  David Spiegel; Janine Giese-Davis
Journal:  Biol Psychiatry       Date:  2003-08-01       Impact factor: 13.382

8.  Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up.

Authors:  Fawzy I Fawzy; Andrea L Canada; Nancy W Fawzy
Journal:  Arch Gen Psychiatry       Date:  2003-01

9.  Flattened cortisol rhythms in metastatic breast cancer patients.

Authors:  Heather C Abercrombie; Janine Giese-Davis; Sandra Sephton; Elissa S Epel; Julie M Turner-Cobb; David Spiegel
Journal:  Psychoneuroendocrinology       Date:  2004-09       Impact factor: 4.905

10.  Psychoneuroendocrine influences on immunocompetence and neoplasia.

Authors:  V Riley
Journal:  Science       Date:  1981-06-05       Impact factor: 47.728

View more
  28 in total

Review 1.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

Review 2.  Host factors and cancer progression: biobehavioral signaling pathways and interventions.

Authors:  Susan K Lutgendorf; Anil K Sood; Michael H Antoni
Journal:  J Clin Oncol       Date:  2010-07-19       Impact factor: 44.544

Review 3.  Biobehavioral influences on cancer progression.

Authors:  Erin S Costanzo; Anil K Sood; Susan K Lutgendorf
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

4.  Mind-body medicine use by women diagnosed with breast cancer: results of a nationally representative survey.

Authors:  Petra Voiß; Melanie Désirée Höxtermann; Gustav Dobos; Holger Cramer
Journal:  Support Care Cancer       Date:  2019-06-11       Impact factor: 3.603

5.  Mind matters in cancer survival.

Authors:  David Spiegel
Journal:  Psychooncology       Date:  2012-03-21       Impact factor: 3.894

Review 6.  Schwann cells: a new player in the tumor microenvironment.

Authors:  Yuri L Bunimovich; Anton A Keskinov; Galina V Shurin; Michael R Shurin
Journal:  Cancer Immunol Immunother       Date:  2016-11-24       Impact factor: 6.968

7.  Psychosocial factors and mortality in women with early stage endometrial cancer.

Authors:  Laura C Telepak; Sally E Jensen; Stacy M Dodd; Linda S Morgan; Deidre B Pereira
Journal:  Br J Health Psychol       Date:  2013-10-23

8.  Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions.

Authors:  Susan K Lutgendorf; Barbara L Andersen
Journal:  Am Psychol       Date:  2015 Feb-Mar

9.  Psychosocially influenced cancer: diverse early-life stress experiences and links to breast cancer.

Authors:  Linda A Schuler; Anthony P Auger
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-07

10.  Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Authors:  Susan K Lutgendorf; Premal H Thaker; Jesusa M Arevalo; Michael J Goodheart; George M Slavich; Anil K Sood; Steve W Cole
Journal:  Cancer       Date:  2017-11-07       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.